SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 27, 1995
BIOTECHNICA INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-11854 22-2344703
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification No.)
incorporation)
4001 North War Memorial Drive, Suite 200, Peoria, IL 61614
(Address of principal executive offices)
Registrant's telephone number, including area code: 309/681-0300
________________________________________________________________
(Former name or former address, if changed since last report)
<PAGE>
ITEM 5. OTHER EVENTS
On June 27, 1995, BioTechnica International, Inc. (the"Corporation")
entered into an agreement with State Farm Mutual Automobile Insurance Company
("State Farm") to repurchase 100% of the Corporation's remaining Class A
Common shares outstanding. The 6,054,751 shares of Class A Common Stock held
by State Farm were purchased at the par value of $.01, resulting in a cash
payment to State Farm of $60,547.51. The Corporation elected to retire the
repurchased shares, reducing the weighted average shares outstanding for the
coming 1995/1996 Fiscal Year by five percent, from 121,368,000 to 115,380,000
shares.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
BIOTECHNICA INTERNATIONAL, INC.
By:J.C. Gouache
J.C. Gouache
President and Chief
Operating Officer
Date: June 29, 1995
